HealthEquity, Inc. (NASDAQ:HQY) will release earnings results for its fourth quarter, after the closing bell on Tuesday, March 17.
Analysts expect the Draper, Utah-based company to report quarterly earnings at 90 cents per share, up from 69 cents per share in the year-ago period. The consensus estimate for HealthEquity's quarterly revenue is $332.82 million, versus $311.82 million a year earlier, according to data from Benzinga Pro.
On Feb. 17, HealthEquity affirmed its FY2027 sales guidance of $1.380 billion to $1.410 billion.
HealthEquity shares rose 1.1% to close at $78.67 on Monday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- Barclays analyst Glen Santangelo maintained an Overweight rating and cut the price target from $118 to $110 on Feb. 18, 2026. This analyst has an accuracy rate of 52%.
- Barrington Research analyst Alexander Paris maintained an Outperform rating with a price target of $125 on Dec. 4, 2025. This analyst has an accuracy rate of 80%.
- JP Morgan analyst Alexei Gogolev maintained an Overweight rating and raised the price target from $126 to $129 on Dec. 4, 2025. This analyst has an accuracy rate of 61%.
- Raymond James analyst C. Gregory Peters maintained a Strong Buy rating and increased the price target from $115 to $120 on July 8, 2025. This analyst has an accuracy rate of 73%.
- Deutsche Bank analyst George Hill maintained a Buy rating and raised the price target from $98 to $115 on June 5, 2025. This analyst has an accuracy rate of 61%.
Considering buying HQY stock? Here’s what analysts think:
Photo via Shutterstock